[Retracted] Management Practice, and Adherence and Its Contributing Factors among Patients with Chronic Kidney Disease at Tikur Anbessa Specialized Hospital: A Hospital Based Cross-Sectional Study

Table 6

Types of regimens used in the management of chronic kidney disease comorbidities patients attending the renal clinic of Tikur Anbessa Specialized Hospital.

Comorbidities	Frequency	Percent ()
Hypertension (n=129)
ACEI based regimens	58	45
Non-ACEI based regimens	71	55
DM + HTN (n=96)
Insulin + ACEI based regimens	55	57.3
ACEI based regimens	19	19.8
Metformin + ACEI based regimens	13	13.5
Insulin + Non-ACEI based regimens	5	5.2
Metformin + Non-ACEI based regimens	4	4.2
DM (n=18)
Insulin	8	44.4
Metformin	6	33.3
Glibenclamide	3	16.7
Insulin + Glibenclamide	1	5.6
IHD (n=33)
ASA + β-Blocker	33	100
Dyslipidemia (n=31)
Statins	31	100
Stroke (n=10)
ASA	10	100
Others (n=12)
ASA + others	7	58.3
Statins + others	5	41.7

DM = diabetes mellitus; HTN = hypertension; IHD = ischemic heart disease; ACEI = angiotensin converting enzyme inhibitor or an angiotensin receptor blocker; ASA = Acetyl Salicylic Acid; asthma, HIV/AIDS, gout, and nephritic syndrome; phenobarbitone, antibiotics, prednisolone, antiretroviral therapy, and carbamazepine.